CD14 and chronic myelogenous leukemia, BCR-ABL1 positive: We also evaluated the ability of serum from patients with CML and exosomes released from leukaemic cells to generate CD14+ HLA‐DR− cells from healthy donor‐derived monocytes and ability of these cells to inhibit T cell proliferation.